BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic … – Genetic Engineering News
Study results showed excellent safety profile, and no serious adverse events were reported during the study. No patient dropped out due to adverse side effects of the treatment. Pharmacokinetic analyses showed no systemic exposure to the active …
